Biology of phospholipase inhibitory proteins.
Biology of phospholipase inhibitory proteins.
复制标题
磷脂酶抑制蛋白的生物学。
DOI:
10.1007/978-1-4613-0651-1_14
复制
发表时间:
1990
影响因子:
--
通讯作者:
Hirata,A
中科院分区:
文献类型:
--
作者:
Hirata,F;Hirata,A
Glucocorticoids are widely used as one of the most efficacious medicines against various inflammatory diseases and allergic diseases including chronic rheumatoid arthritis, lupus erythematosus and bronchial asthma. The mechanism of action is attributed to the anti-inflammatory action, immunosuppressive action and anti-edematous action1. Of these actions, the mode of anti-inflammation is now correlated to the inhibition of release of arachidonic acid, a precursor of prostaglandins (PGs), hydroxyeicosatetraenoic acids (HETEs) and leukotrienes regarded to be inflammatory mediators2. Since the anti-inflammatory action of glucocorticoids with respect to the suppressive effect on the release of eicosanoids can be blocked by inhibitors of protein synthesis as well as mRNA synthesis3, 4, it is conceived that upon entering into a cell, glucocorticoids are first bound to the cytosolic receptor and that the resulting complex is transferred into the nucleus to activate the specific genes, after all, inducing the synthesis of specific proteins5. Although the key enzymes and major sources of arachidonic acid still remain to be established in a quantitative aspect, phospholipase A2(PLA2) and alkylphospholipids have been considered as the important factors6. It is, therefore, suggested that glucocorticoids exhibit their anti-inflammatory action at least partly, if not exclusively, through the induced synthesis of PLA2inhibitory protein(s)7.